Company news
Sana Biotechnology, Inc. news in 2021
Sana Biotechnology, Inc.'s news releases, calls and decks from 2021, newest first.
Sana Biotechnology Presentations at 2021 ASH Annual Meeting Highlight Progress with Platforms and CAR T Cell Programs
December 11, 2021
Sana Biotechnology Reports Third Quarter 2021 Financial Results and Business Updates
November 7, 2021
Sana Biotechnology to Present Pre-Clinical Data at 2021 American Society of Hematology Annual Meeting
November 3, 2021
Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs
October 18, 2021
Sana Biotechnology to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
September 6, 2021
Sana Biotechnology Reports Second Quarter 2021 Financial Results and Business Updates
August 3, 2021
Sana Biotechnology Enters Long-Term Lease to Establish Manufacturing Facility to Enable Its Gene and Cell Therapy Product Candidates
July 13, 2021
Sana Biotechnology Presents Data at ISSCR 2021 Virtual Annual Meeting Showing Survival of Transplanted Hypoimmune Stem Cells Without Immunosuppression in Non-Human Primates
June 25, 2021
Sana Biotechnology to Present During Plenary Sessions at ISSCR 2021 Virtual Annual Meeting
June 13, 2021
Sana Biotechnology to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
June 1, 2021
Sana Biotechnology Reports First Quarter 2021 Financial Results and Business Updates
May 4, 2021
Sana Biotechnology to Present at the BofA Securities 2021 Healthcare Conference
May 3, 2021
Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021
April 26, 2021
Sana Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2021
April 8, 2021
Sana Biotechnology Reports Fourth Quarter and 2020 Financial Results and Business Updates
March 23, 2021
FUJIFILM Cellular Dynamics and Sana Biotechnology Announce License Agreement for the Development of iPSC-Derived Cell Therapies
March 16, 2021
Sana Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
February 7, 2021
Sana Announces Upsized Pricing of Initial Public Offering
February 2, 2021
Decks in 2021
- Investor Presentation (September 2021)
Investor deck · 32 slides · Sep 13, 2021